ArticlePharmaceutics2022

Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects.

Donghyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.